Cargando…

Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target

Detalles Bibliográficos
Autores principales:	Sainaghi, Pier Paolo, Bellan, Mattia, Nerviani, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834835/ https://www.ncbi.nlm.nih.gov/pubmed/33532004 http://dx.doi.org/10.1155/2021/2854925

Ejemplares similares

The Gas6/TAM System and Multiple Sclerosis
por: Bellan, Mattia, et al.
Publicado: (2016)

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
por: Bellan, Mattia, et al.
Publicado: (2020)

Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
por: Bellan, Mattia, et al.
Publicado: (2019)

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
por: Smirne, Carlo, et al.
Publicado: (2019)

Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
por: Rizzi, Manuela, et al.
Publicado: (2023)

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
por: Pagani, Sara, et al.
Publicado: (2020)

Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target
por: Salmi, Livia, et al.
Publicado: (2019)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
por: Wu, Guiling, et al.
Publicado: (2018)

Gas6/TAM Receptors in Systemic Lupus Erythematosus
por: Cohen, Philip L., et al.
Publicado: (2019)

GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis
por: Law, Luke A., et al.
Publicado: (2018)

A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
por: Tutusaus, Anna, et al.
Publicado: (2019)

Molecular insights of Gas6/TAM in cancer development and therapy
por: Wu, Guiling, et al.
Publicado: (2017)

GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
por: Kosta, Andrea, et al.
Publicado: (2022)

Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets
por: Uras, Fikriye, et al.
Publicado: (2015)

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity
por: Kimani, Stanley G., et al.
Publicado: (2017)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Growth Arrest-Specific Gene 6 Administration Ameliorates Sepsis-Induced Organ Damage in Mice and Reduces ROS Formation In Vitro
por: Salmi, Livia, et al.
Publicado: (2021)

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling
por: Cubero, Francisco Javier
Publicado: (2019)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
por: Suh, Chang-Hee, et al.
Publicado: (2010)

Gas6/TAM Signalling Negatively Regulates Inflammatory Induction of GM-CSF in Mouse Brain Microglia
por: Gilchrist, Shannon E., et al.
Publicado: (2021)

COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
por: Rizzi, Manuela, et al.
Publicado: (2023)

Evidence-Based TAM Classic Herbal Formula: From Myth to Science
por: Xiong, Xingjiang, et al.
Publicado: (2017)

Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
por: Bellan, Mattia, et al.
Publicado: (2020)

Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database
por: Gavelli, Francesco, et al.
Publicado: (2022)

Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
por: Bellan, Mattia, et al.
Publicado: (2021)

Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements
por: Baldrighi, Marco, et al.
Publicado: (2018)

TAM Signaling in the Nervous System
por: Burstyn-Cohen, Tal, et al.
Publicado: (2021)

Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022)

Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study
por: Bellan, Mattia, et al.
Publicado: (2022)

Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis
por: Tutusaus, Anna, et al.
Publicado: (2020)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer
por: Nerviani, Alessandra, et al.
Publicado: (2018)

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
por: Yang, Qiyao, et al.
Publicado: (2020)

The Role of TAMs in Tumor Microenvironment and New Research Progress
por: Feng, Yawei, et al.
Publicado: (2022)

Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022)

The TAM family as a therapeutic target in combination with radiation therapy
por: Tormoen, Garth W., et al.
Publicado: (2017)

TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
por: Dayoub, Adam S., et al.
Publicado: (2020)

Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
por: Anagnostakis, Filippos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfg17reck8m4rcfhb3mbhf0gj3